Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.
Description
Harnessing RNA sequencing (RNA-seq) data alongside Artificial Intelligence presents both a crucial necessity and a significant opportunity for creating therapies aimed at correcting splicing errors. By leveraging machine learning, we can uncover novel splicing errors and swiftly formulate therapeutic compounds to address them. Our AI platform, SpliceCore, is specifically designed for discovering RNA therapeutics. This cutting-edge technology focuses on analyzing RNA sequencing data with unparalleled efficiency. It can swiftly identify, evaluate, and validate potential drug targets, outpacing traditional methodologies. Central to SpliceCore is our unique repository containing over 5 million potential RNA splicing errors, making it the largest of its kind globally and instrumental for testing any RNA sequencing dataset submitted for analysis. The integration of scalable cloud computing allows us to handle vast quantities of RNA sequencing data in a way that is not only efficient but also cost-effective, significantly speeding up the pace of therapeutic advancements. This innovative approach promises to revolutionize the landscape of RNA therapeutics.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Altis Labs
Founded
2019
Country
Canada
Website
www.altislabs.com/news/altis-labs-announces-launch-of-nota-a-clinical-information-platform-to-accelerate-therapeutic-r-d
Vendor Details
Company Name
Envisagenics
Founded
2014
Country
United States
Website
www.envisagenics.com/platform/